Rechercher

Nitin Nitin Ajouter une nouvelle offre d'emploi Autre
2025-10-01 10:46:09 -

Biosimilars and Biologics Market to Hit USD 35.4B by 2030, Says DataM Intelligence
Market Overview The Biosimilars and Biologics Market size reached US$531.45 billion in 2024 and is expected to reach US$1,773.77 billion by 2033, growing at a CAGR of 14.4% during the forecast period 2025-2033. The Biosimilars and Biologics Market is booming amid rising chronic diseases and aging populations. These therapies provide targeted treatments for complex conditions like cancer and...

0 Commentaires 0 Parts 538 Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!
Nitin Nitin Ajouter une nouvelle offre d'emploi Autre
2025-10-01 10:46:10 -

Biosimilars and Biologics Market to Hit USD 35.4B by 2030, Says DataM Intelligence
Market Overview The Biosimilars and Biologics Market size reached US$531.45 billion in 2024 and is expected to reach US$1,773.77 billion by 2033, growing at a CAGR of 14.4% during the forecast period 2025-2033. The Biosimilars and Biologics Market is booming amid rising chronic diseases and aging populations. These therapies provide targeted treatments for complex conditions like cancer and...

0 Commentaires 0 Parts 565 Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!
Shweta Jadhav Ajouter une nouvelle offre d'emploi Networking
2025-03-25 07:53:44 -

Biosimilars Market Gaining Traction Due to Cost-Effective Treatment Options
Biosimilars Market Drivers and Trends The surge in chronic diseases such as cancer, diabetes, and autoimmune disorders has heightened the need for affordable therapeutic options. Biosimilars, being cost-effective alternatives to original biologic drugs, offer significant savings for healthcare systems and patients. Additionally, the expiration of patents for several blockbuster biologics...

0 Commentaires 0 Parts 2KB Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!
Priti Shinde Ajouter une nouvelle offre d'emploi Networking
2025-07-01 05:37:16 -

HER2 Antibodies Market by Type (Monoclonal, Biosimilars), Application (Breast, Gastric Cancer), End-User
HER2 Antibodies Market was valued USD 9.37 Bn in 2023 and is expected to reach USD 13.19 Bn by 2030, at a CAGR of 5.0%. HER2 Antibodies Market Overview: Maximize Market Research is a Business Consultancy Firm that has published a detailed analysis of the “HER2 Antibodies Market”. The report includes key business insights, demand analysis, pricing analysis, and competitive...

0 Commentaires 0 Parts 1KB Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!
Priti Shinde Ajouter une nouvelle offre d'emploi Networking
2025-07-01 05:37:16 -

HER2 Antibodies Market by Type (Monoclonal, Biosimilars), Application (Breast, Gastric Cancer), End-User
HER2 Antibodies Market was valued USD 9.37 Bn in 2023 and is expected to reach USD 13.19 Bn by 2030, at a CAGR of 5.0%. HER2 Antibodies Market Overview: Maximize Market Research is a Business Consultancy Firm that has published a detailed analysis of the “HER2 Antibodies Market”. The report includes key business insights, demand analysis, pricing analysis, and competitive...

0 Commentaires 0 Parts 1KB Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!
Healthtech News Ajouter une nouvelle offre d'emploi Health
2025-04-09 05:48:07 -

What Is the Market Outlook for Biosimilars in the Anticancer Drug Segment?
Anticancer Drugs Market Poised for Robust Growth Through 2030 The global anticancer drugs market is experiencing significant expansion, with projections estimating an increase from USD 222.57 billion in 2023 to USD 495.07 billion by 2030. This growth represents a compound annual growth rate (CAGR) of 12.1% during the forecast period. Curious to peek inside? Grab your sample copy of...

0 Commentaires 0 Parts 2KB Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!